Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 06 tags : Phase 2 save search
GSI Technology and Partner Space Micro Awarded NASA Phase 1 Contract for Radiation Tolerant AI Processing in Space
Published: 2021-04-06 (Crawled : 20:00) - globenewswire.com
GSIT | $3.73 0.27% 0.27% 110K
|
Electronic Technology
|
| O: 1.43%
H: 7.05%
C: 6.79%
phase 1 space contract spac technology phase 3 phase 2
Hoth Therapeutics Engages Worldwide Clinical Trials as Contract Research Organization for Phase 2a HT-001 Clinical Trial for Cancer Patients
Published: 2021-04-06 (Crawled : 13:35) - prnewswire.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: -6.64%
phase 2 clinical trials cancer contract research trial phase 2b
Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018™ Adjuvant
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 2.13%
H: 4.49%
C: 0.7%
covid phase 1 positive results vaccine phase 3 phase 2
Molecular Partners Announces First Patient Dosed in a Phase 2 Clinical Trial of Ensovibep in COVID-19 Patients
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.41%
H: 0.67%
C: -0.63%
covid phase 2 molecular trial ensovibep
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: 2.48%
H: 0.35%
C: -9.39%
disease phase 2 dementia parkinson
Scholar Rock Announces Positive 12-Month Top-Line Results From the TOPAZ Phase 2 Clinical Trial Evaluating Apitegromab in Patients With Type 2 and Type 3 Spinal Muscular Atrophy (SMA)
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
SRRK 4 | $14.11 -4.6% -4.82% 430K
|
Health Technology
|
| O: -1.42%
H: 1.15%
C: -19.15%
phase 2 positive results trial topline muscular atrophy
I-Mab and ABL Bio Announce First Patient Dosed in Phase 1 Trial of Bispecific Antibody TJ-L14B/ABL503 in Patients with Advanced or Metastatic Solid Tumors
Published: 2021-04-06 (Crawled : 13:35) - biospace.com/
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -1.72%
H: 6.24%
C: 4.86%
solid tumors phase 1 antibody trial phase 3 phase 2
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
Published: 2021-04-06 (Crawled : 06:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 2.13%
H: 4.49%
C: 0.7%
covid phase 1 positive vaccine vla2001 phase 3 phase 2 covid-19
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.